Clinical Trial Update: Intravitreal Bevacizumab in Agioid Streaks [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating intravitreal bevacizumab for Angioid Streaks with choroidal neovascularization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioid Streaks
• Choroidal Neovascularization

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Angioid Streaks, Choroidal Neovascularization | Phase 1 | Status: COMPLETED